Search - tctmd.com

Displaying 341 - 360 of 433

Sort: Relevancy | Date

Presentation TCT 2012

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Presenter: Michael Farkouh

October 26, 2012

News Conference News TCT 2012

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

October 25, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Conference News TCT 2012

HARVi 1.0 iPad App Explains Fundamentals of Hemodynamics

October 23, 2012

Presentation TCT 2012

TCT-105: Long-term Intravascular Blood Pressure Monitoring with a Novel Wireless Sensor System: Results from Chronic In-Vivo Studies

Presenter: Nina Cleven

October 22, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Industry News

Medtronic Launches New Angioplasty Catheter for Below-the-Knee Arteries

October 05, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Daily News

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

L.A. McKeown

September 10, 2012

News Daily News

La Colocación de un Stent Renal tienen un Gran Potencial Reductor de la Presión Arterial en la Hipertensión Incontrolada

L.A. McKeown

September 10, 2012

Advertisement

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

More Data Needed on Renal Denervation

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

HARVi 1.0 iPad App Explains Fundamentals of Hemodynamics

TCT-105: Long-term Intravascular Blood Pressure Monitoring with a Novel Wireless Sensor System: Results from Chronic In-Vivo Studies

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Medtronic Launches New Angioplasty Catheter for Below-the-Knee Arteries

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

La Colocación de un Stent Renal tienen un Gran Potencial Reductor de la Presión Arterial en la Hipertensión Incontrolada

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content